Medical Condition News

RSS

Research identifies new gene fusions and mutations linked to GIST tumors

Researchers at UC San Diego Moores Cancer Center, with colleagues from Memorial Sloan Kettering Cancer Center and Fox Chase Cancer Center, have determined that a specific region of the small bowel, called the duodenal-jejunal flexure or DJF, shows a high frequency of gastrointestinal stromal tumors (GISTs) with mutations of the NF1 gene

18 Aug 2017

Study finds link between vitamin D deficiency and elevated heart failure risk in older adults

A recent study found an elevated risk of heart failure in more than half of older individuals, and this risk was significantly associated with vitamin D deficiency.

18 Aug 2017

New Global Burden of Disease study estimates vast impact of asthma and COPD

Latest global estimates illustrate the vast impact of the two most common chronic respiratory diseases, with 3.2 million deaths from chronic obstructive pulmonary disease (COPD) and 0.4 million deaths caused by asthma in 2015, according to a new Global Burden of Disease study published in The Lancet Respiratory Medicine journal.

18 Aug 2017

Medical experts explore different ways to enhance situation of patients with myelodysplastic syndromes

More than 70 leading medical specialists, nurses, patient advocates, researchers, regulatory / Health Technology Assessment experts and industry representatives gathered on 3 May 2017 in Valencia, Spain to discuss existing challenges and what is needed to improve the situation of patients affected by myelodysplastic syndromes (MDS).

18 Aug 2017

Air pollution particles could make you more susceptible to infection, say scientists

AIR pollution could make you more vulnerable to infection, scientists at a Scots university have revealed.

18 Aug 2017

MR-guided focused ultrasound continues to gain momentum in treating essential tremor patients

INSIGHTEC announced today that worldwide adoption of MR-guided focused ultrasound continues to gain momentum as Exablate Neuro patient treatment numbers surpass the 1000 mark.

18 Aug 2017

New MyoVista hsECG device launched in the European Union for early detection of heart disease

HeartSciences today announced the European launch of MyoVista high sensitivity electrocardiograph (hsECG) Testing Device, developed in response to the global unmet need for effective, low-cost, front-line screening of cardiac disease in both symptomatic and asymptomatic patients.

18 Aug 2017

New diagnostic tool uses near-infrared light to spot patients at risk of heart attacks and strokes

Patients at risk of heart attacks and strokes may be spotted earlier thanks to a diagnosis tool that uses near-infrared light to identify high-risk arterial plaques, according to research carried out at WMG, University of Warwick, the Baker Institute and Monash University.

18 Aug 2017

New biomarkers for early Lyme Disease identified

A team of researchers led by Colorado State University has developed a test to facilitate early diagnosis of Lyme Disease, which it is hoped will improved treatment outcomes. Until now, it was difficult to distinguish Lyme disease from similar, less severe tick-borne conditions.

18 Aug 2017

Researchers uncover brain mechanism that makes high risk people resilient to bipolar disorder

Researchers from the Icahn School of Medicine at Mount Sinai have identified a brain mechanism in siblings of bipolar patients that makes them resilient to bipolar disorder.

18 Aug 2017

Scientists reveal differences between human and murine microglia used in degenerative disease research

The results of a new research showed that many of the genes that are expressed by microglia are different between humans and mice, which are frequently used as animal models in research on Alzheimer's disease and other neurodegenerative disorders.

18 Aug 2017

Drug blocked by regulators found to improve quality of life for MS patients

A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London.

18 Aug 2017

FDA approves Besponsa – Pfizer’s new drug for rare form of acute lymphoblastic leukemia

The U.S. Food and Drug Administration (FDA) today approved Besponsa (inotuzumab ozogamicin) in the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) - a rare form of ALL.

17 Aug 2017

Peanut allergy successfully kept at bay with immune-based therapy

Australian researchers from the Murdoch Children’s Research Institute have come up with a latest study results showing that peanut allergy could be treated successfully with an immune-based therapy. This new therapy helped children allergic to peanuts eat these nuts with no reactions for up to four years. The study appeared this week in the journal Lancet Child & Adolescent Health.

17 Aug 2017

Community-acquired infections increase with lower kidney function

Individuals with reduced kidney function may be at increased risk of developing infections acquired in the community, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology

17 Aug 2017

Drug-like molecule appears to interfere with inflammatory response in variety of diseases

A drug-like molecule developed by Duke Health researchers appears to intercede in an inflammatory response that is at the center of a variety of diseases, including some cancers, rheumatoid arthritis and Crohn's disease.

17 Aug 2017

New ultra lightweight device for neural recording in mice could transform brain disorder research

Research published this week in Scientific Reports describes a new ultra lightweight system for recording neural activity in the brains of mice.

17 Aug 2017

High-definition eye scan could reveal crucial warning signs of Alzheimer's disease

Cedars-Sinai neuroscience investigators have found that Alzheimer's disease affects the retina – the back of the eye – similarly to the way it affects the brain.

17 Aug 2017

$FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL$

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

The U.S. Food and Drug Administration today approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

17 Aug 2017

Study shows feasibility of noninvasive retinal imaging for screening people at risk of AD

Alzheimer's disease (AD) represents the leading cause of dementia worldwide. Currently, challenges in making an early and definitive diagnosis of AD limit opportunities to intervene with disease-modifying therapies before substantial neurodegeneration occurs.

17 Aug 2017

Medical Condition News

Research identifies new gene fusions and mutations linked to GIST tumors

Study finds link between vitamin D deficiency and elevated heart failure risk in older adults

New Global Burden of Disease study estimates vast impact of asthma and COPD

Medical experts explore different ways to enhance situation of patients with myelodysplastic syndromes

Air pollution particles could make you more susceptible to infection, say scientists

MR-guided focused ultrasound continues to gain momentum in treating essential tremor patients

New MyoVista hsECG device launched in the European Union for early detection of heart disease

New diagnostic tool uses near-infrared light to spot patients at risk of heart attacks and strokes

New biomarkers for early Lyme Disease identified

Researchers uncover brain mechanism that makes high risk people resilient to bipolar disorder

Scientists reveal differences between human and murine microglia used in degenerative disease research

Drug blocked by regulators found to improve quality of life for MS patients

FDA approves Besponsa – Pfizer’s new drug for rare form of acute lymphoblastic leukemia

Peanut allergy successfully kept at bay with immune-based therapy

Community-acquired infections increase with lower kidney function

Drug-like molecule appears to interfere with inflammatory response in variety of diseases

New ultra lightweight device for neural recording in mice could transform brain disorder research

High-definition eye scan could reveal crucial warning signs of Alzheimer's disease

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

Study shows feasibility of noninvasive retinal imaging for screening people at risk of AD

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News